1,987 followers
RT @DrDonaldHarvey: Another example of the reason I truly enjoy working @WinshipAtEmory - great collaborators asking important questions. @…
8,771 followers
RT @DrDonaldHarvey: Another example of the reason I truly enjoy working @WinshipAtEmory - great collaborators asking important questions. @…
10,109 followers
RT @DrDonaldHarvey: Another example of the reason I truly enjoy working @WinshipAtEmory - great collaborators asking important questions. @…
1,794 followers
Another example of the reason I truly enjoy working @WinshipAtEmory - great collaborators asking important questions. @RamalingamMD @teekayowo @wallyjc #oncopharm
2,774 followers
Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trials. @virajmaster @bilenma @DrDonaldHarvey https://t.co/7eRcCTEbi7
813 followers
RT @DylanJMartini: Our paper on sequential #immunotherapy in phase 1 patients is now available https://t.co/vFYrZmE1UM IO-Naïve ➡️ signific…
358 followers
RT @Immunotx_papers: Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trials.…
4,333 followers
RT @DylanJMartini: Our paper on sequential #immunotherapy in phase 1 patients is now available https://t.co/vFYrZmE1UM IO-Naïve ➡️ signific…
358 followers
Very excited about this data and publication!
10,109 followers
RT @DylanJMartini: Our paper on sequential #immunotherapy in phase 1 patients is now available https://t.co/vFYrZmE1UM IO-Naïve ➡️ signific…
329 followers
RT @Immunotx_papers: Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trials.…
329 followers
Our paper on sequential #immunotherapy in phase 1 patients is now available https://t.co/vFYrZmE1UM IO-Naïve ➡️ significantly longer OS Within IO-Naïve, prior IL-2 or IFNγ ➡️ 78% disease control rate Great team effort from the @WinshipAtEmory @EmoryMedici
257 followers
Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trials. https://t.co/mAs7TQYVQd